Corbus Pharmaceuticals Holdings, Inc. (CRBP)
7.83
+0.44
(+5.95%)
USD |
NASDAQ |
Feb 06, 16:00
7.84
+0.01
(+0.13%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings EPS Diluted (Quarterly) : -1.897 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.34M |
| Total Expenses (Quarterly) | 23.34M |
| Enterprise Value | 35.22M |
| Earnings Yield | -70.41% |
| Normalized Earnings Yield | -70.41 |